Guidelines for Completing Individual Research Grant (IRG) Application Form
Please read the following carefully before completing this form. You may wish to use the attached
checklist to help you verify on the completeness of your application before submission. Applications
with insufficient supporting documents and information will have a lower priority over the
others.
How to complete the application form

Follow the instructions closely in every section.

Complete all sections in the application. Indicate “NA” where a particular section is not
applicable. Type your name and the amount of grant applied for in the space provided in every
page of the application form including additional pages, (if any) for identification purposes.

Use Arial font size 10 for all text. Softcopy to be submitted as 1 file including all the pictures,
tables, charts and various attachments either in Word DOC format.

Adhere to the number of characters/space provided in each field and the number of pages
where specified. Reformat softcopy such that all blank or irrelevant pages are removed.

Only one Principal Investigator (PI) is allowed per application. Each PI is only allowed to put in
one application per exercise. There is no limit to the number of Co-PIs or collaborators. The PI
shall be the point of contact for NMRC, with the stated Department and Institution as the hosting
institution. Applicants with multiple appointments at different institutions are to select only one
hosting institution for the application.

The period of support should not be more than 3 years, and the grant amount is capped at
$1million.

Refer and adhere to the list of non-fundable items stated in the NMRC Admin Guidelines
(available on the website and the Budget Section of the Application form). Provide a breakdown
for all categories with justifications and supporting documents such as quotations for all
purchases. Tally and provide both a subtotal amount for each category and the total amount
budgeted.

Include CVs of the PI, Co-PI(s) and all collaborator(s) with the email addresses and contact
information clearly stated.

PI’s original signature is required. The Co-PIs/collaborators’ signatures can be
photostated/faxed copies.
Additional documents required for Re-submission Applications

Append reviewers’ reports of the previous unsuccessful application, together with the
subcommittee’s comments.

On a separate document, itemize how the revised proposal (ie. re-submission application) has
addressed past reviewers’/subcommitte’s comments, and

Highlight new features or merits of the revised proposal.
Additional document required for Renewal Applications

A progress/final report of the existing project to indicate the progress and outputs of the
project in the prescribed NMRC reporting format.
Where to submit your application

Submit 1 soft copy, 1 hardcopy (with original signatures) and 13 photocopies (print on double
side) through your institution’s research coordinator.

For applicants from institution without research coordinator, please submit to :
Manager
National Medical Research Council
226 Outram Road
Block A #02-01
Singapore 169039

NO late submission or revision to the submitted application will be entertained after the closing
date.
NMRC INDIVIDUAL RESEARCH GRANT CHECKLIST
1. PIs are advised to familiarize themselves with the following documents before applying for IRG:
(
)
NMRC Administrative Guidelines and Financial Regulation (available on web)
(
)
Memorandum of Understanding (if available at your institution)
2. Your Application Form (Format from NMRC website) should consist of the following:
(
)
Category of Research Proposal
(
)
Title of Research
(
)
Total Amount
(
)
Period of Support
(
)
Key Words
(
)
Field of Research
(
)
Ethical Considerations
(
)
Abstract
(
)
Details of Research Proposal (aims, clinical significance, prelim studies, methodology,
references)
(
)
Biographical Sketch of PI & all collaborators
(
)
Budget breakdown & Justifications (manpower, equipment, consumables, miscellaneous)
(
)
Cash Flow Projection
(
)
Milestones
(
)
Performance Indicators
(
)
Other support
(
)
Suggested Names of Reviewers
(
)
Research Director/ Department Head Signature and Comments
(
)
Signatories
(
)
Additional documents (1. Past reviewers’ reports, 2. Address reviewers’ comments, 3. New
features/merits) for re-submission applications, as instructed in the Guidelines on completing
IRG application. Progress/ Final Report for Renewal applications.
3. Please submit through your institution research coordinator:
(
)
1 x Hard copy including original signatures
(
)
13 x Photocopies
(
)
1 x Soft copy (1 file including all attachments either in Word DOC or PDF format)
For official use only-application ID
NATIONAL MEDICAL RESEARCH COUNCIL
NMRC
National Medical
Research Council
Application for Individual Research Grant (IRG)
All information is treated in confidence. The information is furnished to the National Medical Research Council with the
understanding that it shall be used or disclosed for evaluation, reference and reporting purposes . If your application is not
successful, this form will be destroyed after the retention period deemed as appropriate by the Council.
1 Category of research proposal
Please ‘click’ the appropriate box
a)
New
Resubmission (Application ID
)
Renewal
(Grant number NMRC/
/
)
b) Is this proposal listed under your Institutional Block Grant?
c)
Clinical
Yes
No
Translational
2 Title of research (Limit to 300 characters)
Applicant
Role
Position
Department
PI
Collab
Collab
Collab
Collab
Collab
Collab
Collab
Collab
Collab
Collab
Collab
End
(Attach additional sheet if required)
3 Total amount of funds applied for SGD
(max $1 million)
4 (a) Period of Support requested 0.5 years (max 3 years)
1
Institution
Name of Principal Investigator:
Amount applied for:
(b) Proposed start and end dates
Please allow 6 months for the review process.
Start date
End date
(mm/yy)
(mm/yy)
5 Key words (Please provide maximum 6 key words)
6 Field of research
Please fill in the Area ID below with reference to the list attached (Appendix 1).
Main Area :
Sub Area :
7 Ethical considerations and containment
Fund disbursement is subjected to ethics approval if the project involves any of the below.
Please declare the
participating institutions
where study requiring
ethics approval is
conducted:
Please tick accordingly if project involves any of the following:
a) Human Subject
Yes
No
b) Use of Human Tissues or Cells
Yes
No
c) Animal Experimentation
Yes
No
d) Requirement for Containment
Yes
No
e) Multi-centre project(s) or trial(s)
Yes
No
(If yes, please state all participating institutions/centres :
)
A copy of the ethics approval is attached:
Yes
No
2
Name of Principal Investigator:
Amount applied for:
8
Abstract
In no more than 300 words, concisely describe the specific aims, hypotheses, methodology and approach of the
research proposal including its importance to science or medicine in particular clinical significance. The abstract
must be self-contained so that it can serve as a succinct and accurate description of the research proposal.
3
Name of Principal Investigator:
Amount applied for:
9 Research proposal
In no more than 12 pages, organize the details of the research proposal under the following headings: 9.1
Specific aims, 9.2 Clinical significance, 9.3 Preliminary studies/Progress reports, 9.4 Methods and 9.5
References.
9.1 Specific Aims
State concisely and realistically what the pilot study intends to accomplish and/or what hypothesis is to be
tested.
9.2 Clinical Significance
Briefly sketch the background of the research proposed, critically evaluate existing knowledge and specifically
identify the gaps which the project intended to fill. State concisely the importance of the research described by
relating the specific aims to possible longer term objectives. State the significance of the research to clinical
application and tangible improvements in healthcare that may result from the study. Relevant references should
be appended.
9.3 Preliminary Studies/Progress Reports
For NEW APPLICATIONS, provide an account of the Principal Investigator’s preliminary studies (if any) pertinent
to the applications and/or any other information that will help to establish the experience and competence of the
investigator pursuing the proposed project.
For RENEWAL APPLICATIONS, give the beginning and end dates of the period covered since the research
project was last reviewed. Provide a succinct account of published and unpublished results, indicating the
importance of the findings. Discuss any changes in the project’s specific aims during the periods covered. List
the titles and complete references to all publications and completed manuscripts that have resulted from the
project.
9.4 Methods
Discuss in detail the experimental design and the procedure to be used to accomplish the specific aims of the
project. Describe the protocols to be used and the tentative sequence of the investigation. Include statistical
justification and the means by which data will be analysed and interpreted. Describe any new methodology and
its advantage over existing methodologies. Discuss the potential difficulties and limitations of the proposed
procedures and alternative approaches to achieve the aims. Point out any procedures, situations or materials
that may be hazardous to personnel and the precautions to be exercised. Make every attempt to be succinct.
9.5 References
Please list in chronological order the titles and complete references to recent representative publications
pertinent to this research proposal and the applicants’ publications and patents held related to this research
proposal. Highlight Scientific Award(s), if any, of the applicant(s).
4
Name of Principal Investigator:
Amount applied for:
10 Biographical Sketch
In not more than 2 pages per applicant, please use the format below to provide the required information on the
Principal Investigator (PI), co-PI(s) and all Collaborator(s).












Name
NRIC/Passport No.
Office Mailing Address
Email
Contact No
Fax No
Current Position (Please provide full details, e.g. joint appointments)
Academic qualifications (Indicate institution’s name and year degree awarded)
Selected publications (not more than 6 relevant publications)
Research interests
Recent awards
Current and previous support from NMRC or other sources
(Please also include proposals pending approval)
5
Name of Principal Investigator:
Amount applied for:
11 Budget
You are advised to prepare the budget carefully under each category and provide the justifications for all
categories in Item 11.5.
The following items are non-fundable under IRGs, unless specifically approved by the NMRC:















Equipment already funded by IBGs
Administrative charges from Institutions
Handphones
Laptops
Overhead costs such as facilities management, TOL (i.e. rental of space) and utilities charges
Pagers
Personal computers
Printers and Accessories
Refreshments
Relocation expenses
Renovation expenses
Stationery
Patenting expenses
Contingency funds
Any other items that the Council finds inappropriate
11.1 Manpower
Please budget for all the manpower required for the project including part-time personnel and those to be shared
with other projects. State whether they are existing personnel in your institution or new staff to be recruited.
Please use salary scales provided by the Bursar’s Office, Hospital Administration or the Ministry of Health as a
reference. The cost should include annual increments, National Service increment, staff welfare, medical and
other related benefits as per the Human Resource policies of your institution.
Staff Category
Existing/New
Technologist
New
Research
Assistant
New
Research Officer
New
Research
Associate
New
Postdoctoral
Fellow
New
Others:
(please specify)
New
No
Remarks
Total cost
Total
6
$0.00
Name of Principal Investigator:
Amount applied for:
11.2 Equipment
Please budget for all scientific equipment you need to purchase to carry out the project. Indicate sharing of
equipment with other projects, if any.
Qty
Equipment
Unit Cost
Total
7
Sub- Total
$0.00
Name of Principal Investigator:
Amount applied for:
11.3
Materials & Supplies
Please budget for all materials and supplies required specifically for the project such as experimental animals
and consumables.
Item Description
Cost
Animals
Consumables
Others:
(please specify)
Total
11.4
$0.00
Miscellaneous
This category covers other expenses directly related to the project such as the purchase of laboratory manuals,
literature search, and maintenance of equipment. Conference travel will be funded only if a presentation or if an
article is presented. The presentation or article must be directly related to the project.
Item Description
Cost
Total
$0.00
Grand Total: SGD$0.00
8
Name of Principal Investigator:
Amount applied for:
11.5
Details and Justifications of Financial Assistance Requested
Please provide breakdown for all categories if this is not indicated in the tables.
11.5.1 Manpower
Justifications
11.5.2 Equipment
Justifications
11.5.3 Materials & Supplies
Justifications
11.5.4 Miscellaneous
Justifications
9
Name of Principal Investigator:
Amount applied for:
12 Cash flow Projection
Please project the cash flow in accordance with your proposed start and end dates to assist the NMRC
administration in cash flow projection.
Category
FY2007
FY2008
FY2009
FY2010
(1 Apr’0731 Mar’08)
(1 Apr’0831 Mar’09)
(1 Apr’0931 Mar’10)
(1 Apr’1031 Mar’11)
Total
Manpower
0
Equipment
0
Materials & Supplies
0
Miscellaneous
0
Total costs by year
0
0
0
0
13 Milestones
Please propose Milestones for assessment of the progress of the study. The progress of the project will be
taken into consideration for continued disbursements of funds.
Targeted Duration/Date of
Fulfillment
Milestones
10
Name of Principal Investigator:
Amount applied for:
14 Performance Indicators
Please indicate the final expected targets. Please state ‘NA’ where indicator is not applicable.
Performance Indicators
Master’s research students trained
PhD students trained *
Training R&D
manpower for
industry
Master’s research and PhD students trained and
spun out to local industry as RSEs
Research staff spun out to local industry as RSEs
Post-doctoral (within 3 years of the PhD award)
researchers hired
Joint programs/projects with prestigious international
research organizations
Joint programs/projects with local universities
Capability
Indicators
Invention disclosures
Patents filed
Developing
long term R&D
capability
Patents granted
Patents commercialized
Papers published in international journals *
(To state impact factor)
Presentations at international conferences
Awards for research at national and international
level
R&D
collaboration
Industry
Relevance
Indicators
R&D projects with industry cash funding
Industry dollars received to fund R&D projects
Revenue from royalties and licensing agreements
Outcomes
Spin-off companies registered
New products or processes commercialized
*NMRC place special emphasis on these targets.
11
Indicate
number /
value
Name of Principal Investigator:
Amount applied for:
15 Other Support
Please provide the following details for the grants currently held or being applied for by the Principal Investigator.
Attach additional pages if necessary.
(a) Grants currently held
Please indicate the NMRC grant number for all NMRC-funded research projects.
Title of Research
Funding
Agency
Amount of Fund
Approved/
Received ($)
Balance
Available ($)
Support
Period
(Year)
Expiry
Date of the
grant
(b) Grants applying for
Please indicate the application ID for all NMRC grant applications.
Title of Research
Funding Agency
Amount of fund
applied for ($)
Support Period
(Year)
(c) Support not related to specific research projects
Provide below details of ALL other support which are not derived from funds provided for specific research
projects, such as departmental technicians, grants from private foundations, start-up funds, donations from
charitable organizations and collaborations with industry. You may also attach correspondences showing
commitments by other parties in support of your work.
Types of resources
Funding
Organisations
12
Duration of
support
Expiry date, if any
Name of Principal Investigator:
Amount applied for:
16 Suggested names of Reviewers
S/N
Title
Names of Reviewers
Details
(tel, fax number and e-mail add)
1
2
3
Proposals should not be sent to
(a)
(b)
(c)
13
Relationship to
Principal
Investigator
Name of Principal Investigator:
Amount applied for:
17 Institutional support
Department Head:
_____________________
___
Date: __________________
Name, Designation, Institution & Signature
If the Head of Department is involved in this proposal, please seek support from
immediate supervisor:
Comments:
** Supported/ Not Supported (please indicate)
Director of Research:
_____________________
___
Date: __________________
Name, Designation, Institution & Signature
If the Director of Research is involved in this proposal, please seek support from
immediate supervisor:
Comments:
** Supported/ Not Supported (please indicate)
14
18 Signatories
The undersigned agree to abide by the conditions governing the award of research grants set out by
the National Medical Research Council of Singapore.
_______________ _______________ _______________ ______________
Principal Investigator
Name:
Date:
Collaborator
Name:
Date:
Collaborator
Name:
Date:
Collaborator
Name:
Date:
_______________ _______________ _______________ ______________
Collaborator
Name:
Date:
Collaborator
Name:
Date:
Collaborator
Name:
Date:
Collaborator
Name:
Date:
_______________ _______________ _______________ ______________
Collaborator
Name:
Date:
Collaborator
Name:
Date:
Collaborator
Name:
Date:
15
Collaborator
Name:
Date:
Classification of Fields of Research
Appendix 1
1 Immunology / Microbiology
0101 Autoimmunity
0113
Medical Bacteriology
0102 Biotechnology not elsewhere classified
0114
Medical Infection Agents (incl. Prions)
0103 Cell Metabolism
0115
Medical Microbiology not elsewhere classified
0104 Cell Physiology
0116
Medical Mycology
0105 Cellular Immunology
0117
Medical Parasitology
0106 Dentistry not elsewhere classified
0118
Medical Virology
0107 Epidemiology
0119
Molecular Evolution
0108 Genetic Immunology
0120
Oncology and Carcinogenesis
0109 Humoral Immunology & Immunochemistry 0121
Population and Ecological Genetics
0110 Immunogenetics
0122
Respiratory Diseases
0111 Immunology not elsewhere classified
0123
Therapies and Therapeutic Technology
0112 Infectious Diseases
0124
Transplantation Immunology
2 Pathology / Inflammation / Oncology / Nuclear Medicine
0201 Rheumatology and Arthritis
0219 Medical Bacteriology
0202 Allergy
0220 Medical Genetics
0203 Biochemistry and Cell Biology not
0221 Medical Parasitology
elsewhere classified
0204 Cell Development (incl. Cell Division and
0222 Medical Virology
Apoptosis)
0205 Cell Metabolism
0223 Molecular Evolution
0206 Cellular Immunology
0224 Nephrology and Urology
0207 Cellular Interactions (incl. Adhesion, Matrix, 0225 Neurology and Neuromuscular Diseases
Cell Wall)
0208 Dermatology
0226 Oncology and Carcinogenesis
0209 Diagnostic Applications
0227 Pathology
0210 Endocrinology
0228 Protein Targeting and Signal Transduction
0211 Gastroenterology
0229 Quantitative Genetics
0212 Gene Expression
0230 Radiotherapy and Nuclear Medicine
0213 Gene Therapy
0231 Respiratory Diseases
0214 Genetic Immunology
0232 Sensory Systems
0215 Genome Structure
0233 Therapies and Therapeutic Technology
0216 Haematology
0234 Transgenesis
0217 Immunology not elsewhere classified
0235 Transplantation Immunology
0218 Infectious Diseases
0236 Tumour Immunology
16
3 Biochemistry / Cell Biology / Cell and Molecular Biology
0301 Analytical Biochemistry
0318 Medical Bacteriology
0302 Biochemistry & Cell Biology not elsewhere 0319 Medical Biochemistry: Carbohydrates
classified
0303 Cardiology (incl. Cardiovascular Diseases) 0320 Medical Biochemistry: Lipids
0304 Cell Development (incl. Cell Division and
0321 Medical Biochemistry: Nucleic Acids
Apoptosis)
0305 Cell Metabolism
0322 Medical Biochemistry: Other
0306 Cell Physiology
0323 Medical Biochemistry: Phospholipids
0307 Cellular Interactions (incl. Adhesion, Matrix, 0324 Medical Biochemistry: Proteins and Peptides
Cell Wall)
0308 Dermatology
0325 Medical Biotechnology
0309 Diagnostic Applications
0326 Medical Mycology
0310 Endocrinology
0327 Medical Physiology not elsewhere classified
0311 Enzymes
0328 Membrane Biology
0312 Gastroenterology
0329 Neurology and Neuromuscular Diseases
0313 Gene Expression
0330 Nutrition and Dietetics
0314 Haematology
0331 Protein Targeting and Signal Transduction
0315 Human Biophysics
0332 Reproduction
0316 Immunology not elsewhere classified
0333 Rheumatology and Arthritis
0317 Infectious Diseases
0334 Therapies and Therapeutic Technology
4 Epidemiology / Health Sciences / Public Health & Health Services
0401 Aged Care Nursing
0402 Applied Statistics
0403 Biological Psychology (Neuropsychology,
Psychopharmacology, Physiological
Psychology)
0404 Cardiology (incl. Cardiovascular Diseases)
0405 Care for Disabled
0406 Clinical Nursing: Primary (Preventative)
0407 Clinical Nursing: Secondary (Acute Care)
0408 Clinical Nursing: Tertiary (Rehabilitative)
0409 Community Child Health
0410 Environmental and Occupational Health and
Safety
0411 Epidemiology
0412 Health and Community Services
0413 Health Care Administration
0414 Health Counselling
0415 Health Economics
0416 Health Information Systems (incl.
Surveillance)
0417 Health Promotion
0423 Medical and Health Sciences not elsewhere
classified
0424 Medical Bacteriology
0425 Medical Genetics
0426
0427
0428
0429
0430
0431
0432
Medical Parasitology
Mental Health Nursing
Midwifery
Molecular Evolution
Nephrology and Urology
Neurology and Neuromuscular Diseases
Nursing not elsewhere classified
0433
0434
0435
0436
0437
Oncology and Carcinogenesis
Paediatrics
Preventive Medicine
Primary Health Care
Psychological Methodology, Design and
Analysis
Public Health & Health Services not elsewhere
classified
Rehabilitation and Therapy: Hearing and
Speech
Rehabilitation and Therapy: Occupational and
Physical
Residential Client Care
Respiratory Diseases
Rheumatology and Arthritis
Social and Community Psychology
0438
0439
0418 Health, Clinical and Counselling Psychology 0440
0419
0420
0421
0422
Human Bioethics
Indigenous Health
Infectious Diseases
Learning, Memory, Cognition and Language
0441
0442
0443
0444
17
5 Peripheral/ Cellular Nervous System / Sensory Nervous System / Central Nervous System /
Mental Health
0501 Autonomic Nervous System
0502 Basic Pharmacology
0503 Biochemistry & Cell Biology not elsewhere
classified
0504 Biological Psychology (Neuropsychology,
Psychopharmacology, Physiological
Psychology)
0505 Biophysics
0506 Cardiology (incl. Cardiovascular
Diseases)
0507 Cell Development (incl. Cell Division and
Apoptosis)
0508 Cell Neurochemistry
0509 Cell Physiology
0510 Cellular Nervous System
0511 Central Nervous System
0512 Clinical Pharmacology and Therapeutics
0513 Clinical Sciences not elsewhere classified
0514 Complementary/Alternative Med not
elsewhere classified
0515 Dentistry not elsewhere classified
0516 Developmental Psychology and Ageing
0517 Endocrinology
0518 Epidemiology
0519 Genetic Development (incl. Sex
Determination)
0520 Genetics not elsewhere classified
0521 Genetics not elsewhere classified
0522 Health, Clinical and Counselling
Psychology
0523 Human Movement & Sports Sci not
elsewhere classified
0524 Immunology not elsewhere classified
0525 Instruments and Techniques
0526 Learning, Memory, Cognition and Language
0527 Medical Physiology not elsewhere classified
0528 Mental Health
0529 Motor Control
0530 Neurogenetics
0531 Neurology and Neuromuscular Diseases
0532
0533
0534
0535
0536
0537
0538
Neurosciences not elsewhere classified
Oncology and Carcinogenesis
Ophthalmology and Vision Science
Optometry not elsewhere classified
Otorhinolaryngology
Peripheral Nervous System
Protein Targeting and Signal Transduction
0539 Psychiatry
0540 Psychology not elsewhere classified
0541 Rehabilitation & Therapy: Occupational and
Physical
0542 Rehabilitation and Therapy: Hearing and
Speech
0543 Sensory Processes, Perceptions and
Performance
0544 Sensory Systems
0545 Surgery
0546 Systems Physiology
0547 Therapies and Therapeutic Technology
18
6 Genetics / Paediatrics / Reproduction
0601 Anaesthesiology
0602 Biotechnology not elsewhere classified
0603 Cardiology (incl. Cardiovascular Diseases)
0604 Cell Development (incl. Cell Division and
Apoptosis)
0605 Cell Metabolism
0606 Cell Physiology
0607 Clinical Sciences not elsewhere classified
0608 Diagnostic Applications
0609 Endocrinology
0610 Epidemiology
0611 Foetal Development and Medicine
0612 Gene Expression
0613 Gene Therapy
0614 Genetic Development (incl. Sex
Determination)
0615 Genetic Immunology
0616 Genetic Technologies: Transformation,
Site-directed Mutagenesis, etc.
0617 Genetics not elsewhere classified
0618 Immunogenetics
0619 Intensive Care
7 Cardiovascular / Respiratory
0701 Anaesthesiology
0702 Biomechanics
0703 Cardiology (incl. Cardiovascular Diseases)
0704 Cell Metabolism
0705 Cell Physiology
0706 Clinical Sciences not elsewhere classified
0707 Epidemiology
0708 Exercise Physiology
0620 Medical and Health Sciences not elsewhere
classified
0621 Medical Bacteriology
0622 Medical Genetics
0623 Medical Physiology not elsewhere classified
0624
0625
0626
0627
0628
0629
0630
0631
0632
0633
Medical Virology
Meiosis and Recombination
Molecular Evolution
Nutrition and Dietetics
Obstetrics and Gynaecology
Oncology and Carcinogenesis
Paediatrics
Population and Ecological Genetics
Quantitative Genetics
Reproduction
0634 Respiratory Diseases
0635 Systems Physiology
0636 Therapies and Therapeutic Technology
0637 Therapies and Therapeutic Technology
0709
0710
0711
0712
0713
0714
0715
19
Foetal Development and Medicine
Intensive Care
Medical Physiology not elsewhere classified
Respiratory Diseases
Sports Medicine
Systems Physiology
Therapies and Therapeutic Technology
8 Renal / Endocrinology / Pharmacology
0801 Anaesthesiology
0802 Basic Pharmacology
0803 Biochemistry and Cell Biology not
elsewhere classified
0804 Biomechanics
0805 Cardiology (incl. Cardiovascular Diseases)
0806 Cell Development (incl. Cell Division and
Apoptosis)
0807 Cell Metabolism
0808 Cell Physiology
0809 Clinical Pharmacology and Therapeutics
0810 Complementary/Alternative Med. not
elsewhere classified
0811 Endocrinology
0812 Exercise Physiology
0813 Genetic Development (incl. Sex
Determination)
0814 Intensive Care
0815 Medical and Health Sciences not
elsewhere classified
0816 Medical and Health Sciences not
elsewhere classified
9 GIT/ Liver/ Nutrition
0901 Autonomic Nervous System
0902 Cell Metabolism
0903 Cell Physiology
0904 Clinical Sciences not elsewhere classified
0905 Endocrinology
0906 Gastroenterology
0907 Gene Expression
0908 Geriatrics and Gerontology
0909 Hepatology
10 Dentistry/Surgery/ Ophthalmology
1001 Biological Psychology (Neuropsychology,
Psychopharmacology,Physiological
Psychology)
1002 Biomaterials
1003 Biomechanical Engineering
1004 Biomedical Engineering not elsewhere
classified
1005 Biophysics
1006 Biotechnology not elsewhere classified
1007 Cardiology (incl. Cardiovascular Diseases)
1008 Dentistry not elsewhere classified
1009
1010
1011
1012
0817 Medical Bacteriology
0818 Medical Parasitology
0819 Medical Physiology not elsewhere classified
0820 Nephrology and Urology
0821 Oriental Medicine and Treatments
0822 Otorhinolaryngology
0823
0824
0825
0829
Pharmaceutical Sciences and Pharmacy
Pharmacology not elsewhere classified
Respiratory Diseases
Sports Medicine
0830 Systems Physiology
0831 Therapies and Therapeutic Technology
0832 Toxicology (incl. Clinical Toxicology)
0817 Medical Bacteriology
0818 Medical Parasitology
0819 Medical Physiology not elsewhere classified
0910
0911
0912
0913
0914
0915
0916
0917
Medical Bacteriology
Medical Physiology not elsewhere classified
Nutrition and Dietetics
Paediatrics
Protein Targeting and Signal Transduction
Radiotherapy and Nuclear Medicine
Surgery
Systems Physiology
1013 Medical Physics
1014 Medical Physiology not elsewhere classified
1015 Orthopaedics
1016 Otorhinolaryngology
1017
1018
1019
1020
Paediatrics
Radiology and Organ Imaging
Radiotherapy and Nuclear Medicine
Rehabilitation & Therapy: Occupational &
Physical
Instruments and Techniques
1021 Respiratory Diseases
Intensive Care
1022 Rhematology and Arthritis
Medical and Health Sciences not elsewhere 1023 Surgery
classified
Medical Microbiology not elsewhere
classified
20